BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38697774)

  • 1. Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
    Ford AC; Staudacher HM; Talley NJ
    Gut; 2024 Jun; 73(7):1199-1211. PubMed ID: 38697774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Diet on Symptoms of the Irritable Bowel Syndrome.
    Spiller R
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33572262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.
    Fisher K; Hutcheon D; Ziegler J
    Nutr Clin Pract; 2020 Apr; 35(2):231-245. PubMed ID: 30937981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia.
    Zuo XL; Li YQ; Li WJ; Guo YT; Lu XF; Li JM; Desmond PV
    Clin Exp Allergy; 2007 Jun; 37(6):823-30. PubMed ID: 17517095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
    Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
    Talley NJ; Holtmann G; Walker MM
    J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
    Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
    Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet in irritable bowel syndrome.
    El-Salhy M; Gundersen D
    Nutr J; 2015 Apr; 14():36. PubMed ID: 25880820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome.
    Colomier E; Van Oudenhove L; Tack J; Böhn L; Bennet S; Nybacka S; Störsrud S; Öhman L; Törnblom H; Simrén M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
    Chumpitazi BP
    Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
    Wong WM
    Singapore Med J; 2016 Sep; 57(9):476-84. PubMed ID: 27664186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FODMAPs in Patients With Irritable Bowel Syndrome.
    Mansueto P; Seidita A; D'Alcamo A; Carroccio A
    Nutr Clin Pract; 2015 Oct; 30(5):665-82. PubMed ID: 25694210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
    Chey WD; Hashash JG; Manning L; Chang L
    Gastroenterology; 2022 May; 162(6):1737-1745.e5. PubMed ID: 35337654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review.
    Okawa Y; Fukudo S; Sanada H
    Biopsychosoc Med; 2019; 13():10. PubMed ID: 31080496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in diagnosis and management of irritable bowel syndrome.
    Van den Houte K; Colomier E; Schol J; Carbone F; Tack J
    Curr Opin Psychiatry; 2020 Sep; 33(5):460-466. PubMed ID: 32639360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Low-FODMAPS Diet on Irritable Bowel Syndrome Symptoms and Gut Microbiome.
    Su H; Li YT; Heitkemper MM; Zia J
    Gastroenterol Nurs; 2019; 42(2):150-158. PubMed ID: 30946302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.